Rheumnow Podcast

ACR24 PsA Topic Panel Advancing Care for Psoriatic Arthritis

Tune in for an engaging discussion at the ACR Annual Meeting! This expert panel will explore the latest breakthroughs and trends in Psoriatic Arthritis(PsA) research and management, providing actionable insights for clinicians and researchers.

ACR 2024 Rheumatology Roundup Featuring Drs. Artie Kavanaugh and Jack Cush

Highlight presentations from ACR 2024 in Washington, DC
Covered abstracts include:
- Dr. Kavanaugh
1679 Amplified & biomarkers
0082 Enthesitis Pathology & IL-23
1553 TLR 7/8 inhibitors in SLE
995 Carbon footprint to injectables
L20 ARTHUR DIANA Automated US
1132 VEGA (Combo Rx – see also 2640, 1460, 1393)
1745 Statin use in Oral Surveillance

- Dr. Cush
458 Seronegative RA fate
L19 Emapalumab in Stills disease
ACR 2024 updated guidelines on lupus nephritis
2580 Ianalumab in SLE
2259 Anti-Obesity Meds in RA
2657 Mortality with starting/stopping steroids
0774  TAPIR study in GCA
1697  PMR MODE study

ACR24 SpA Topic Panel Key Discussions on Spondyloarthritis

Join us as we dive into expert insights from the ACR Annual Meeting! This special panel will focus on the latest research and advancements in Spondyloarthritis (SpA), featuring thought leaders in the field.
Dr. Marina Magrey
Cleveland
Dr. Lihi Eder
Toronto
Dr. Sheila Reyes
Phillipines
Dr. Adela Castro
Memphis

ACR24 - RHEUMATOID ARTHRITIS

A New ACR
Cancer Survival in RA
"Changing Mindsets about Methotrexate Side Effects"
Control RA, Build Stronger Bones
Cumulative Steroid Use and Cardiovascular Events
Disease Activity in RA-ILD
Do TNFis and JAKis Prevent Cancer!?
Estimating Inflammation, Damage and Patient Distress
Finding the Right Combination Therapy in RA
Implantable Vagus Nerve Stimulator for RA
Is Frequent Lab Monitoring Necessary?
Long Term Follow up from APIPPRA
Metabolic Dysregulation and RA Interstitial Lung Disease
Native Americans with RA Die Young
Paraoxonase-1: Possible Biomarker for Progression to RA
Pred Softly: Steroids
Predicting Flares in Rheumatoid Arthritis
RA Roundup: Is LDA Inappropriate? What about Statins for JAKs?
RA Treatment Adherence: Is decision making really shared?
RA: One JAK to Rule Them All?
Sonelokimab in PsA: Phase 2 Data
Treat-to-Target Improves Fertility in Women with RA
Treatment Considerations for RA-ILD
Treatment Strategies in RA
Use of AI in Hand Ultrasound Scoring
Vaccine Responses:The DMARD Counts
What's New in Relapsing Polychondritis?
What's The State of Biosimilars?

ACR24 - IL-17

A New ACR
Anti IL-17 on Entheseal Biopsy in PsA
axSpA: Impact of TNF and IL-17 in Patients with Prior TNF Exposure
Best Things I Saw Today in PsA
Cycling vs Switching after TNFi Failure in axSpA
Improvements in Pain and Fatigue in Bimekizumab
Long-term Safety Profile of Bimekizumab in axSpA and PsA
Sonelokimab in PsA: Phase 2 Data
Treating SpA

ACR24 - JAK_TYK2

A New ACR
Best Things I Saw Today in PsA
Do TNFis and JAKis Prevent Cancer!?
Hold or continue JAKi and IL-17 when receiving COVID boosters?
JAK-pot! How fast do DMARDs work?
JAKi Studies at ACR
Poly-treatment of Polymyalgia Rheumatica?
RA Roundup: Is LDA Inappropriate? What about Statins for JAKs?
RA: One JAK to Rule Them All?
SELECT-GCA: Efficacy and Safety of Upadacitinib
"SELECT-GCA: Upadacitinib in Giant Cell Arteritis"
SELECTing the right patients: upadacitinib in GCA
So really, are JAKs Safe?
Summary of JAKi Studies
The Case for JAKi in PMR
The Real Value of JAKi is Beyond RA
When, What and How Long to Treat GCA & PMR
Worried about CV Risk and JAKi? What about the Steroids?

ACR24 - LUPUS

A Fibroblast Renaissance
A New ACR
A useful urinary biomarker for lupus nephritis
ANA+ and no Autoimmune Disease? Check the liver
CAR-T Therapy and Lupus
Cyclophosphomide vs Mycophenolate vs Tacrolimus in Lupus Nephritis
Evaluating ANA Patterns and Titers with AI
Neuropsychiatric Lupus: The Forgotten Symptoms
The 2024 ACR Guidelines for Lupus Nephritis
Vaccine Responses:The DMARD Counts
What is MCTD? The Great Debate

 

ACR24 - SPONDYLOARTHRITIS

A New ACR
Assessing ASAS Criteria: CLASSIC Study Results
Assessment and management of axSpA
Assessment of axSpA
Carotid Doppler Ultrasound Screening in Axial SpA
Cycling vs Switching after TNFi Failure in axSpA
Defining Difficult to Manage axSpA
Difficult to manage AxSpA
DISH in SpA
Gender Differences in AxSpA
Highlights in axSpA
Hot Topics in axSpA
Long-term Safety Profile of Bimekizumab in axSpA and PsA
Machine Learning for Predicting Flares in axSpA
Precision Immunotherapy in Axial SpA
PREDICT-SpA: Evaluating the influence of gender on disease assessment tools
Treating SpA
What is a Positive MRI in Spondyloarthritis?
axSpA: Impact of TNF and IL-17 in Patients with Prior TNF Exposure

ACR24 - PSORIATIC ARTHRITIS

A New ACR
Apremilast Benefits and Risks in PsA
Best Things I Saw Today in PsA
Bimekizumab in PsA Showed Sustained Reductions in Disease Impact
Biologic Monotherapy vs Combination with cDMARDs in PsA
Do TNFis and JAKis Prevent Cancer!?
Improvements in Pain and Fatigue in Bimekizumab
Long-term Safety Profile of Bimekizumab in axSpA and PsA
Potential Impact of Weight Loss Drugs in Rheumatic Diseases
Proposed ACR Guidance for Use of MSUS in Psoriatic Arthritis
PsA Potpourri
PsA Ultrasound Updates
PsA: Impact of Sex
Sex Differences in Psoriatic Arthritis
The Psoriatic March: PsA before PsO
Apremilast in PsA: Results from Mosaic Trial
Anti IL-17 on Entheseal Biopsy in PsA

ACR24 - Day4c

Is Frequent Lab Monitoring Necessary?:Dr. Bella Mehta
The Case for JAKi in PMR:Dr. David Liew
Treatment Strategies in RA:Dr. Victoria Konzett
What's New in Relapsing Polychondritis?:Dr. Bella Mehta 
Worried about CV Risk and JAKi? What about the Steroids?:Dr. David Liew